4 Healthcare Stocks for Investors to Check Out
ViroPharma Incorporated (NASDAQ:VPHM): Closing price $25.40
United States District Judge Ellen Segal Huvelle in Washington dismissed ViroPharma’s suit against the FDA concerning generic forms of the firm’s antibiotic Vancocin, as it company failed to produce new evidence following an April rejection of its request for a court order to disallowFDA approval of three generic versions of the drug. Huvelle said that “ViroPharma all but admits that it has presented no substantially new arguments, but rather relies on additional elaboration, none of which persuades the court to reverse itself.” The judge upheld the FDA’s rejection of ViroPharma’s request for three years of market exclusivity for Vancocin on the basis of a labeling change.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>